• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强化降脂治疗可改善急性心肌梗死患者的大动脉弹性。

Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients.

作者信息

Jia Xinwei, Wei Meng, Fu Xianghua, Gu Xinshun, Fan Weize, Zhang Jing, Xue Ling

机构信息

Cardiovascular Department, Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China.

出版信息

Heart Vessels. 2009 Sep;24(5):340-6. doi: 10.1007/s00380-008-1132-z. Epub 2009 Sep 27.

DOI:10.1007/s00380-008-1132-z
PMID:19784816
Abstract

This study was aimed at probing the effects of intensive cholesterol-lowering therapy with simvastatin on the large artery elasticity of acute myocardial infarction patients. A total of 72 cases of acute myocardial infarction patients were divided into a normocholesterol group (n = 37) and a hypercholesterol group (n = 35) according to their serum low-density lipoprotein. All patients were given oral simvastatin 40 mg/day for 6 months, and their pulse-wave velocity (PWV) of different artery segments and ankle-brachial index (ABI) were measured before and after the therapy. The low-density lipoprotein cholesterol level in both groups decreased significantly (2.13 +/- 0.32 vs 1.56 +/- 0.28, 3.43 +/- 0.80 vs 2.28 +/- 0.47 mmol/l, P < 0.01). The PWV of each artery segment in both the normocholesterol group and the hypercholesterol group decreased significantly (P < 0.05). Pulse-wave velocity in the hypercholesterol group was lowered much more than that of the normocholesterol group (P < 0.05). There were no differences among each artery segment in each group. Ankle-brachial index increased significantly in both groups (1.12 +/- 0.16 to 1.22 +/- 0.12, P < 0.05 in the normocholesterol group, and 1.03 +/- 0.22 to 1.23 +/- 0.16, P < 0.01 in the hypercholesterol group), but ABI increased much more in the hypercholesterol group than in the normocholesterol group (0.21 + 0.15 vs 0.11 + 0.09 P = 0.02). Intensive cholesterol-lowering therapy with simvastatin for acute myocardial infarction patients can significantly improve their large artery elasticity and regress their atherosclerosis. Hypercholesterol patients benefit more from this therapy.

摘要

本研究旨在探讨辛伐他汀强化降脂治疗对急性心肌梗死患者大动脉弹性的影响。根据血清低密度脂蛋白水平,将72例急性心肌梗死患者分为正常胆固醇组(n = 37)和高胆固醇组(n = 35)。所有患者均口服辛伐他汀40 mg/天,共6个月,并在治疗前后测量不同动脉节段的脉搏波速度(PWV)和踝臂指数(ABI)。两组患者的低密度脂蛋白胆固醇水平均显著降低(2.13±0.32 vs 1.56±0.28,3.43±0.80 vs 2.28±0.47 mmol/l,P < 0.01)。正常胆固醇组和高胆固醇组各动脉节段的PWV均显著降低(P < 0.05)。高胆固醇组的脉搏波速度下降幅度远大于正常胆固醇组(P < 0.05)。每组各动脉节段之间无差异。两组患者的踝臂指数均显著升高(正常胆固醇组:1.12±0.16至1.22±0.12,P < 0.05;高胆固醇组:1.03±0.22至1.23±0.16,P < 0.01),但高胆固醇组的ABI升高幅度大于正常胆固醇组(0.21 + 0.15 vs 0.11 + 0.09,P = 0.02)。辛伐他汀强化降脂治疗急性心肌梗死患者可显著改善其大动脉弹性并使动脉粥样硬化消退。高胆固醇患者从该治疗中获益更多。

相似文献

1
Intensive cholesterol-lowering therapy improves large artery elasticity in acute myocardial infarction patients.强化降脂治疗可改善急性心肌梗死患者的大动脉弹性。
Heart Vessels. 2009 Sep;24(5):340-6. doi: 10.1007/s00380-008-1132-z. Epub 2009 Sep 27.
2
Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.辛伐他汀和普伐他汀在改善男性高胆固醇血症患者的血流介导的血管舒张方面效果相当。
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):999-1003.
3
Simvastatin improves arterial compliance in the lower limb but not in the aorta.辛伐他汀可改善下肢动脉顺应性,但对主动脉无效。
Atherosclerosis. 2001 Mar;155(1):245-50. doi: 10.1016/s0021-9150(00)00558-x.
4
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.高剂量阿托伐他汀与常规剂量辛伐他汀用于心肌梗死后二级预防:IDEAL研究:一项随机对照试验。
JAMA. 2005 Nov 16;294(19):2437-45. doi: 10.1001/jama.294.19.2437.
5
The effect of simvastatin, ezetimibe and their combination on the lipid profile, arterial stiffness and inflammatory markers.辛伐他汀、依折麦布及其联合用药对血脂谱、动脉僵硬度和炎症标志物的影响。
Eur J Clin Pharmacol. 2007 Feb;63(2):113-21. doi: 10.1007/s00228-006-0238-4. Epub 2007 Jan 3.
6
A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial.辛伐他汀与瑞舒伐他汀治疗急性心肌梗死患者的随机对照试验:急性冠状动脉事件二级预防——将胆固醇降至欧洲关键目标试验
Eur J Cardiovasc Prev Rehabil. 2009 Dec;16(6):712-21. doi: 10.1097/HJR.0b013e3283316ce8.
7
Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.低密度脂蛋白单采术对高胆固醇血症合并冠状动脉疾病患者外周血管疾病的影响。
Ann Intern Med. 1996 Dec 15;125(12):945-54. doi: 10.7326/0003-4819-125-12-199612150-00001.
8
Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.降低血脂以降低冠状动脉疾病风险的指南:瑞舒伐他汀与阿托伐他汀、普伐他汀和辛伐他汀在实现降脂目标方面的比较。
Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C. doi: 10.1016/s0002-9149(03)00004-3.
9
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.依折麦布/辛伐他汀长期治疗家族性高胆固醇血症患者的疗效与安全性。
Int Angiol. 2010 Dec;29(6):514-24.
10
Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined.在辛伐他汀和依那普利单独或联合作用下,高胆固醇血症冠心病患者的内皮依赖性反应。
Am Heart J. 2000 Oct;140(4):684-9. doi: 10.1067/mhj.2000.109649.

引用本文的文献

1
Association Between Telomere G-Tail Length and Coronary Artery Disease or Statin Treatment in Patients With Cardiovascular Risks - A Cross-Sectional Study.心血管风险患者端粒G尾长度与冠状动脉疾病或他汀类药物治疗之间的关联——一项横断面研究
Circ Rep. 2023 Jul 11;5(8):338-347. doi: 10.1253/circrep.CR-23-0038. eCollection 2023 Aug 10.
2
Effects of High- or Moderate-intensity Rosuvastatin on 1-year Major Adverse Cardiovascular Events Post-percutaneous Coronary Intervention.高强度或中等强度瑞舒伐他汀对经皮冠状动脉介入治疗后1年主要不良心血管事件的影响。
Interv Cardiol. 2022 Nov 29;17:e20. doi: 10.15420/icr.2022.13. eCollection 2022 Jan.
3

本文引用的文献

1
Therapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention.他汀类药物和阿司匹林治疗可改善经皮冠状动脉介入治疗的长期疗效。
Heart Vessels. 2008 Jan;23(1):35-9. doi: 10.1007/s00380-007-1007-8. Epub 2008 Feb 14.
2
Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens.接受他汀类药物治疗的患者在颈动脉内膜切除术标本中的斑块内血管生成减少。
Atherosclerosis. 2007 Jun;192(2):457-63. doi: 10.1016/j.atherosclerosis.2007.01.035. Epub 2007 Feb 28.
3
Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study.
Improvement in Brachial Endothelial Vasomotor Function and Brachial-Ankle Pulse Wave Velocity Reduces the Residual Risk for Cardiovascular Events after Optimal Medical Treatment in Patients with Coronary Artery Disease.
经最佳药物治疗后,肱动脉内皮血管舒缩功能和肱踝脉搏波速度改善可降低冠心病患者的心血管事件残余风险。
J Atheroscler Thromb. 2021 Nov 1;28(11):1133-1144. doi: 10.5551/jat.57562. Epub 2020 Nov 20.
4
Improving Arterial Wall Characteristics in Patients After Myocardial Infarction with a Very Low Dose of Fluvastatin and Valsartan: A Proof-of-Concept Study.研究证实:小剂量氟伐他汀联合缬沙坦可改善心肌梗死后患者的动脉壁特性。
Med Sci Monit. 2018 Sep 29;24:6892-6899. doi: 10.12659/MSM.908967.
5
Gender and Age Differences in Short- and Long-Term Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后短期和长期预后的性别与年龄差异
Acta Cardiol Sin. 2014 Jul;30(4):274-83.
6
A Combination of Low Doses of Fluvastatin and Valsartan Decreases Arterial Stiffness in Patients After Myocardial Infarction: A Pilot Study.低剂量氟伐他汀与缬沙坦联合应用可降低心肌梗死后患者的动脉僵硬度:一项初步研究。
Curr Ther Res Clin Exp. 2015 Jun 6;77:63-5. doi: 10.1016/j.curtheres.2015.06.001. eCollection 2015 Dec.
7
Impacts of age on coronary atherosclerosis and vascular response to statin therapy.年龄对冠状动脉粥样硬化及他汀类药物治疗血管反应的影响。
Heart Vessels. 2014 Jul;29(4):456-63. doi: 10.1007/s00380-013-0387-1. Epub 2013 Jun 30.
8
Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count.冠状动脉粥样硬化消退预测模型的开发:高密度脂蛋白胆固醇水平和外周血单核细胞计数的评估
Heart Vessels. 2012 Mar;27(2):143-50. doi: 10.1007/s00380-011-0130-8. Epub 2011 Mar 18.
9
Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide.氟伐他汀有益的血管活性内皮效应:关注前列环素和一氧化氮。
Heart Vessels. 2011 Nov;26(6):628-36. doi: 10.1007/s00380-010-0097-x. Epub 2011 Jan 7.
10
Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up.在一项为期2年的随访中,西洛他唑可减缓急性冠脉综合征患者颈动脉内膜中层厚度的进展,且不会增加出血风险。
Heart Vessels. 2011 Sep;26(5):502-10. doi: 10.1007/s00380-010-0093-1. Epub 2010 Dec 9.
单次给予HMG-CoA还原酶抑制剂西立伐他汀可改善冠状动脉血流速度储备:一项经胸多普勒超声心动图研究。
Heart Vessels. 2006 Sep;21(5):298-301. doi: 10.1007/s00380-006-0905-5. Epub 2006 Sep 29.
4
Relation between local temperature and C-reactive protein levels in patients with coronary artery disease: effects of atorvastatin treatment.冠心病患者局部温度与C反应蛋白水平的关系:阿托伐他汀治疗的影响
Atherosclerosis. 2007 Jun;192(2):396-400. doi: 10.1016/j.atherosclerosis.2006.05.038. Epub 2006 Jul 3.
5
Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients.在接受治疗的非糖尿病高血压患者中,C反应蛋白与动脉僵硬度存在显著关联。
Atherosclerosis. 2007 Jun;192(2):401-6. doi: 10.1016/j.atherosclerosis.2006.05.025. Epub 2006 Jun 19.
6
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.美国心脏协会/美国心脏病学会关于冠心病及其他动脉粥样硬化性血管疾病患者二级预防的指南:2006年更新版,得到美国国立心肺血液研究所认可。
J Am Coll Cardiol. 2006 May 16;47(10):2130-9. doi: 10.1016/j.jacc.2006.04.026.
7
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.高剂量阿托伐他汀与常规剂量辛伐他汀用于心肌梗死后二级预防:IDEAL研究:一项随机对照试验。
JAMA. 2005 Nov 16;294(19):2437-45. doi: 10.1001/jama.294.19.2437.
8
Augmentation of pulse wave velocity precedes vascular structural changes of the aorta in rats treated with N(omega)-nitro-L-arginine methyl ester.在用N(ω)-硝基-L-精氨酸甲酯处理的大鼠中,脉搏波速度的增加先于主动脉的血管结构变化。
Hypertens Res. 2005 May;28(5):439-45. doi: 10.1291/hypres.28.439.
9
Obesity is associated with increased arterial stiffness from adolescence until old age.从青春期到老年,肥胖都与动脉僵硬度增加有关。
J Hypertens. 2005 Oct;23(10):1839-46. doi: 10.1097/01.hjh.0000179511.93889.e9.
10
Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.阿托伐他汀对2型糖尿病患者局部动脉僵硬度的影响。
J Atheroscler Thromb. 2005;12(4):205-10. doi: 10.5551/jat.12.205.